Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome.
I Bernardini, … , J Bernar, W A Gahl
I Bernardini, … , J Bernar, W A Gahl
Published April 1, 1985
Citation Information: J Clin Invest. 1985;75(4):1124-1130. https://doi.org/10.1172/JCI111806.
View: Text | PDF
Research Article

Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome.

  • Text
  • PDF
Abstract

Plasma and urine free and acyl carnitine were measured in 19 children with nephropathic cystinosis and renal Fanconi syndrome. Each patient exhibited a deficiency of plasma free carnitine (mean 11.7 +/- 4.0 [SD] nmol/ml) compared with normal control values (42.0 +/- 9.0 nmol/ml) (P less than 0.001). Mean plasma acyl carnitine in the cystinotic subjects was normal. Four subjects with Fanconi syndrome but not cystinosis displayed the same abnormal pattern of plasma carnitine levels; controls with acidosis or a lysosomal storage disorder (Fabry disease), but not Fanconi syndrome, had entirely normal plasma carnitine levels. Two postrenal transplant subjects with cystinosis but without Fanconi syndrome also had normal plasma carnitine levels. Absolute amounts of urinary free carnitine were elevated in cystinotic individuals with Fanconi syndrome. In all 21 subjects with several different etiologies for the Fanconi syndrome, the mean fractional excretion of free carnitine (33%) as well as acyl carnitine (26%) greatly exceeded normal values (3 and 5%, respectively). Total free carnitine excretion in Fanconi syndrome patients correlated with total amino acid excretion (r = 0.76). Two cystinotic patients fasted for 24 h and one idiopathic Fanconi syndrome patient fasted for 5 h showed normal increases in plasma beta-hydroxybutyrate and acetoacetate, which suggested that hepatic fatty acid oxidation was intact despite very low plasma free carnitine levels. Muscle biopsies from two cystinotic subjects with Fanconi syndrome and plasma carnitine deficiency had 8.5 and 13.1 nmol free carnitine per milligram of noncollagen protein, respectively (normal controls, 22.3 and 17.1); total carnitines were 11.8 and 13.3 nmol/mg noncollagen protein (controls 33.5, 20.0). One biopsy revealed a mild increase in lipid droplets. The other showed mild myopathic features with variation in muscle fiber size, small vacuoles, and an increase in lipid droplets. In renal Fanconi syndrome, failure to reabsorb free and acyl carnitine results in a secondary plasma and muscle free carnitine deficiency.

Authors

I Bernardini, W B Rizzo, M Dalakas, J Bernar, W A Gahl

×

Total citations by year

Year: 2025 2022 2021 2020 2017 2015 2014 2012 2011 2010 2009 2008 2007 2006 2005 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1984 Total
Citations: 1 1 1 3 1 1 2 2 1 1 1 2 2 2 4 1 1 4 1 1 1 3 2 5 3 1 1 3 4 3 5 4 1 1 70
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (70)

Title and authors Publication Year
Novel mechanism for tubular injury in nephropathic cystinosis
Sur S, Kerwin M, Pineda S, Sansanwal P, Sigdel TK, Sirota M, Sarwal MM
eLife 2025
Assessment of carnitine excretion and its ratio to plasma free carnitine as a biomarker for primary carnitine deficiency in newborns.
Crefcoeur LL, Heiner-Fokkema MR, Maase RE, Visser G, de Sain-van der Velden MGM
JIMD reports 2022
Clinical and neurophysiological characterization of early neuromuscular involvement in children and adolescents with nephropathic cystinosis
N Elkhateeb, R Selim, NA Soliman, FM Atia, II Abouelwoun, MA Elmonem, R Helmy
Pediatric Nephrology 2021
Challenges in Analysis of Hydrophilic Metabolites Using Chromatography Coupled with Mass Spectrometry
Q Hu, H Tang, Y Wang
2020
Kinetics of Serum Carnitine Fractions in Patients With Chronic Kidney Disease Not on Dialysis
J Yano, S Ito, G Kodama, Y Nakayama, Y Kaida, Y Yokota, Y Kinoshita, K Tashiro, K Fukami
The Kurume Medical Journal 2020
Carnitine promotes recovery from oxidative stress and extends lifespan in C. elegans
D Liu, X Zeng, L Li, ZL Ou
Aging 2020
Comprehensive Analysis of Acylcarnitine Species in db/db Mouse Using a Novel Method of High-Resolution Parallel Reaction Monitoring Reveals Widespread Metabolic Dysfunction Induced by Diabetes
L Xiang, J Wei, XY Tian, B Wang, W Chan, S Li, Z Tang, H Zhang, WS Cheang, Q Zhao, H Zhao, Z Yang, Y Hong, Y Huang, Z Cai
Analytical Chemistry 2017
Carnitine insufficiency in children with inborn errors of metabolism: prevalence and treatment efficacy
I Mamedov, I Zolkina, E Nikolaeva, P Glagovsky, V Sukhorukov
Journal of Pediatric Endocrinology and Metabolism 2015
JIMD Reports
M Besouw, E Cornelissen, D Cassiman, L Kluijtmans, L Heuvel, E Levtchenko
JIMD reports 2014
Carnitine Metabolism and Human Nutrition
S Wicks, R Noland, R Mynatt
Carnitine Metabolism and Human Nutrition 2014
Cystinosis: the evolution of a treatable disease
G Nesterova, WA Gahl
Pediatric Nephrology 2012
Carnitine and Acylcarnitines: Pharmacokinetic, Pharmacological and Clinical Aspects
SE Reuter, AM Evans
Clinical Pharmacokinetics 2012
Fanconi Syndrome Associated with Valporic Acid: A Case Report
R Shiari, L Bagherzade, MR Alaei
Iranian Red Crescent Medical Journal 2011
Role of carnitine in cancer chemotherapy-induced multiple organ toxicity
MM Sayed-Ahmed
Saudi Pharmaceutical Journal 2010
Increased Insulin Sensitivity in Mice Lacking Collectrin, a Downstream Target of HNF-1α
SM Malakauskas, WM Kourany, XY Zhang, D Lu, RD Stevens, TR Koves, HE Hohmeier, DM Muoio, CB Newgard, TH Le
Molecular Endocrinology 2009
Carnitine deficiency and l-carnitine supplementation in lysinuric protein intolerance
LM Tanner, K Näntö-Salonen, MS Rashed, S Kotilainen, M Aalto, J Venetoklis, H Niinikoski, K Huoponen, O Simell
Metabolism 2008
Nephropathic cystinosis: late complications of a multisystemic disease
G Nesterova, W Gahl
Pediatric Nephrology 2008
L-carnitine supplementation in the dialysis population: Are Australian patients missing out?
SE Reuter, RJ Faull, AM Evans
Nephrology 2007
Side Effects of Drugs Annual
T Vial, J Descotes, F Braun, M Behrend
Side Effects of Drugs Annual 2007
Disposition and Metabolite Kinetics of Oral L-carnitine in Humans
MA Bain, RW Milne, AM Evans
The Journal of Clinical Pharmacology 2006
Physician’s Guide to the Treatment and Follow-Up of Metabolic Diseases
N Blau, J Leonard, GF Hoffmann, JT Clarke
2006
Nutrition in Exercise & Sport
J Cooper, P Deuster
Sports Nutrition 2005
The use of levo-carnitine in children with renal disease: a review and a call for future studies
B Belay, N Esteban-Cruciani, CA Walsh, FJ Kaskel
Pediatric Nephrology 2005
Debate Forum: Levocarnitine Therapy Is Rational and Justified in Selected Dialysis Patients
BD Schreiber
Blood Purification 2005
Atlas of Metabolic Diseases Second edition
W Nyhan, B Barshop, P Ozand
Atlas of Metabolic Diseases Second edition 2005
Pharmacokinetics of L-Carnitine:
AM Evans, G Fornasini
Clinical Pharmacokinetics 2003
Infantile cystinosis presenting as chronic constipation
FK Assadi, RH Sandler, PW Wong, M Salem, L Simenauer
American Journal of Kidney Diseases 2002
Laboratory approach to mitochondrial diseases
D Parra, A González, C Mugueta, A Martínez, I Monreal
Journal of Physiology and Biochemistry 2001
Evaluation of Urinary Carnitine and Taurine Excretion in 5 Cystinuric Dogs with Carnitine and Taurine Deficiency
SL Sanderson, CA Osborne, JP Lulich, JW Bartges, ME Pierpont, PN Ogburn, LA Koehler, LL Swanson, KA Bird, LK Ulrich
Journal of Veterinary Internal Medicine 2001
Effect of gamma-butyrobetaine on fatty liver in juvenile visceral steatosis mice
Y Higashi, K Yokogawa, N Takeuchi, I Tamai, M Nomura, N Hashimoto, J I Hayakawa, K I Miyamoto, A Tsuji
The Journal of pharmacy and pharmacology 2001
Carnitine-Deficient Myopathy as a Presentation of Tyrosinemia Type I
A Nissenkom, SH Korman, O Vardi, A Levine, Z Katzir, A Ballin, T Lerman-Sagie
Journal of child neurology 2001
Metabolic myopathies: a clinical approach; part II
BT Darras, NR Friedman
Pediatric Neurology 2000
Lipid storage myopathy in a cocker spaniel
SR Platt, CL Chrisman, GD Shelton
Journal of Small Animal Practice 1999
GENETIC DISORDERS OF CARNITINE METABOLISM AND THEIR NUTRITIONAL MANAGEMENT1
J Kerner, C Hoppel
Annual Review of Nutrition 1998
Carnitine metabolism changes during the first year after a successful kidney transplantation
Z Zdrojewski, E Kisielnicka, E Król, J Fox, G Kuchta, B Rutkowski, W Łysiak-Szydłowska
Transplantation Proceedings 1997
Carnitine metabolism in patients with chronic liver disease: Carnitine metabolism in patients with chronic liver disease
S Krähenbühl, J Reichen
Hepatology 1997
Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS
WN Suki, SG Massry
1997
Carnitine metabolism in chronic liver disease
S Krähenbühl
Life Sciences 1996
L-Carnitine
JH Walter
Archives of disease in childhood 1996
Cystinosis
JG Thoene
Journal of Inherited Metabolic Disease 1995
Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features
BL Clarke, AG Wynne, DM Wilson, LA Fitzpatrick
Clinical Endocrinology 1995
Medullary nephrocalcinosis in nephropathic cystinosis
DS Theodoropoulos, TH Shawker, C Heinrichs, WA Gahl
Pediatric Nephrology 1995
Intraoperative hyperthermia in a paediatric patient with cystinosis
JP Purday, CJ Montgomery, D Blackstock
Pediatric Anesthesia 1995
Renal handling of carnitine in ill preterm and term neonates
S Zamora, N Benador, G Lacourt, E Girardin
The Journal of Pediatrics 1995
Distal vacuolar myopathy in nephropathic cystinosis
LR Charnas, CA Luciano, M Dalakas, RW Gilliatt, I Bernardini, K Ishak, VA Cwik, D Fraker, TA Brushart, WA Gahl
Annals of Neurology 1994
Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage
MC Dalakas, ME Leon-Monzon, I Bernardini, WA Gahl, CA Jay
Annals of Neurology 1994
Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine transport system
M Horiuchi, K Kobayashi, S Yamaguchi, N Shimizu, T Koizumi, H Nikaido, J Hayakawa, M Kuwajima, T Saheki
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1994
Neurologic Emergencies in Infancy and Childhood
AM Chutorian, SG Pavlakis
Neurologic Emergencies in Infancy and Childhood 1993
Indian childhood cirrhosis in an American child
M Adamson, B Reiner, JL Olson, Z Goodman, L Plotnick, I Bernardini, WA Gahl
Gastroenterology 1992
Animal model of systemic carnitine deficiency: Analysis in C3H-H-2° strain of mouse associated with juvenile visceral steatosis
M Kuwajima, N Kono, M Horiuchi, Y Imamura, A Ono, Y Inui, S Kawata, T Koizumi, J Hayakawa, T Saheki, S Tarui
Biochemical and Biophysical Research Communications 1991
Clinical and Laboratory Findings in the Oculocerebrorenal Syndrome of Lowe, with Special Reference to Growth and Renal Function
LR Charnas, I Bernardini, D Rader, JM Hoeg, WA Gahl
New England Journal of Medicine 1991
Treatment of cystinosis with cysteamine from early infancy
VM Reznik, M Adamson, RD Adelman, JL Murphy, WA Gahl, KF Clark, JA Schneider
The Journal of Pediatrics 1991
The effect of carnitine supplementation on carnitine balance in patients with persistent post-operative infection
M Soop, E Forsberg, A Thörne, G Cederblad, J Wahren
Clinical Nutrition 1990
Update on nephropathic cystinosis
JA Schneider, B Katz, RB Melles
Pediatric Nephrology 1990
Carnitine deficiency
SC Winter, EM Zorn, WH Vance, RA Chalmers, MD Bain, TE Stacey, CD Sousa
The Lancet 1990
Carnitine Metabolism and Usage in Chronic Dialysis Patients
PS Kurtin
Seminars in Dialysis 1990
Analysis of acylcarnitines in normal human urine with the radioisotopic exchange-high performance liquid chromatography (HPLC) method
E Schmidt-Sommerfeld, D Penn, J Kerner, LL Bieber
Clinica Chimica Acta 1989
Urine glyceraldehyde excretion is elevated in the renal Fanconi syndrome
AJ Jonas, SN Lin, SB Conley, JA Schneider, JC Williams, RC Caprioli
Kidney International 1989
CARNITINE DEFICIENCY INDUCED BY PIVAMPICILLIN AND PIVMECILLINAM THERAPY
E Holme, CE Jacobson, I Nordin, J Greter, S Lindstedt, B Kristiansson, U Jodal
The Lancet 1989
Transsulfuration in an adult with hepatic methionine adenosyltransferase deficiency
WA Gahl, I Bernardini, JD Finkelstein, A Tangerman, JJ Martin, HJ Blom, KD Mullen, SH Mudd
Journal of Clinical Investigation 1988
Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome
WA Gahl, I Bernardini, M Dalakas, WB Rizzo, GS Harper, JM Hoeg, O Hurko, J Bernar
Journal of Clinical Investigation 1988
Myopathy and Cystine Storage in Muscles in a Patient with Nephropathic Cystinosis
WA Gahl, MC Dalakas, L Charnas, KT Chen, GH Pezeshkpour, T Kuwabara, SL Davis, RW Chesney, J Fink, HT Hutchison
New England Journal of Medicine 1988
Myopathies Caused by Disorders of Lipid Metabolism
JE Carroll
Neurologic Clinics 1988
Lipoprotein lipase, hepatic lipase, and carnitine in premature infants
LM Rovamo, EA Nikkila, KO Raivio
Archives of disease in childhood 1988
Hepatic methionine adenosyltransferase deficiency in a 31-year-old man
WA Gahl, JD Finkelstein, KD Mullen, I Bernardini, JJ Martin, P Backlund, KG Ishak, JH Hoofnagle, SH Mudd
The American Journal of Human Genetics 1987
Removal of Corneal Crystals by Topical Cysteamine in Nephropathic Cystinosis
MI Kaiser-Kupfer, L Fujikawa, T Kuwabara, S Jain, WA Gahl
New England Journal of Medicine 1987
Cysteamine Therapy for Children with Nephropathic Cystinosis
WA Gahl, GF Reed, JG Thoene, JD Schulman, WB Rizzo, AJ Jonas, DW Denman, JJ Schlesselman, BJ Corden, JA Schneider
New England Journal of Medicine 1987
Complications of nephropathic cystinosis after renal failure
WA Gahl, MI Kaiser-Kupfer
Pediatric Nephrology 1987
Carnitine: An overview of its role in preventive medicine
BS Kendler
Preventive Medicine 1986
Therapy of Renal Diseases and Related Disorders
WN Suki, SG Massry
1984

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts